title: Drug treatment of Parkinson's disease: is "polypharmacy" best?
authors.affiliation: Division of Neurology, University of Washington School of Medicine, Seattle 98195.
authors.forename: P D
authors.initials: PD
authors.lastname: Swanson
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents